Privi Speciality (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Privi Speciality Chemicals Limited |
|||
|
Price: ₹1,502.80 (-0.37%) | ||
| 52 Week Low: ₹975.00 52 Week High: ₹2,017.00 |
|||
| Market Capital: 4,316.23 Crore (Smallcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Privi Speciality Share Price Target For 2025
- 1.1.1: Privi Speciality Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Privi Speciality Share Price Target For 2026
- 1.2.1: Privi Speciality Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Privi Speciality Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Privi Speciality Brief Company Overview
- 4: Privi Speciality Financial Performance
- 4.0.1: Is Privi Speciality A Good Buy For Long Term?
Privi Speciality, a Small Cap company in the Specialty Chemicals Industry has delivered 202.6% returns in 5-year showing 21.5% quarterly revenue growth with 5.4% profit margin, making it a potential Multibagger.
To predict the Privi Speciality's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Privi Speciality Share Price Target For 2025
The line chart displays the monthly closing prices of Privi Speciality with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Privi Speciality shares in 2025, see the table below.
Privi Speciality Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1691.0 (+12.52%) | Price Action: 26 Dec 2024 Low |
| 2025 Target 2 | 1674.0 (+11.39%) | Price Action: 11 Feb 2025 Low |
| 2025 Target 1 | 1654.6 (+10.1%) | Price Action: 30 Jul 2024 High |
| Current Price | 1502.80 | Privi Speciality's share price as of 25 Feb 2025 |
| Stop Loss 1 | 1435.4 (-4.49%) | Price Action: 19 Aug 2024 Low |
| Stop Loss 2 | 1419.75 (-5.53%) | Price Action: 28 Jun 2024 Low |
| Stop Loss 3 | 1405.1 (-6.51%) | Price Action: Aug 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Privi Speciality is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1675.14 serves as the nearest technical reference point.
Historical Returns: 3-month: -21.26% | 6-month: +2.23% | 1-year: +28.02%
Privi Speciality Share Price Target For 2026
The line chart displays the monthly closing prices of Privi Speciality with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Privi Speciality shares in 2026, see the table below.
Privi Speciality Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 2263.22 (+50.6%) | Fibonacci Extension Level 123.60% |
| 2026 Target 2 | 2201.7 (+46.5%) | Price Action: Chart |
| 2026 Target 1 | 2179.9 (+45.05%) | Fibonacci Extension Level 64.90% |
| Current Price | 1502.80 | Privi Speciality's share price as of 25 Feb 2025 |
| Stop Loss 1 | 1347.76 (-10.32%) | Price Action: Dec 2023 High |
| Stop Loss 2 | 1333.0 (-11.3%) | Price Action: 21 Jun 2024 Low |
| Stop Loss 3 | 1317.0 (-12.37%) | Price Action: 13 Dec 2023 High |
Long-Term Technical Outlook
52-Week Range Analysis: Privi Speciality is currently trading at 50.7% of its 52-week range (₹975 - ₹2017).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +28.02% | 3-year: -19.75% | 5-year: +202.62%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Privi Speciality Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,502.80 | ||
| 2025 | ₹2,799.56 | +86.28% | ₹2,841.55 |
| 2026 | ₹3,941.81 | +40.8% | ₹4,000.94 |
| 2027 | ₹5,796.15 | +47.04% | ₹5,883.09 |
| 2028 | ₹7,744.47 | +33.61% | ₹7,860.64 |
| 2029 | ₹10,383.52 | +34.07% | ₹10,539.27 |
| 2030 | ₹13,828.22 | +33.17% | ₹14,035.64 |
| 2031 | ₹17,174.46 | +24.19% | ₹17,432.08 |
| 2032 | ₹21,534.92 | +25.38% | ₹21,857.94 |
| 2033 | ₹27,467.88 | +27.55% | ₹27,879.90 |
| 2034 | ₹32,803.99 | +19.42% | ₹33,296.05 |
| 2035 | ₹41,629.86 | +26.9% | ₹42,254.31 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Privi Speciality Brief Company Overview
Privi Specialty Chemicals Limited: A Comprehensive Overview Privi Specialty Chemicals Limited, formerly known as Fairchem Speciality Limited, is a renowned manufacturer and exporter of aroma and fragrance chemicals, catering to a global clientele. The company's diverse product...
range includes aroma chemicals, amber fleur, acetates, dihydromyrcenol, ionones, nitriles, sandal wood derivatives, and specialty chemicals. Founded in 1985, Privi Speciality Chemicals has earned a reputation for excellence in the industry, with a strong presence in India, North America, Asia, the Middle East, Africa, Europe, and the United Kingdom. The company is committed to providing high-quality products and services, meeting the diverse needs of its customers worldwide.Privi Speciality Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 4,316.23 Crore | Market valuation of Privi Speciality's shares. |
| Revenue (TTM) | 1,752.23 Crore | Total revenue generated by Privi Speciality over the past twelve months. |
| Net Income (TTM) | +94.9 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.68% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +5.41% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+21.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+22.22% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
107.12 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1,008.18 Crore | Sum of Privi Speciality's current & long-term financial obligations. |
| Total Cash | 68.34 Crore | Total amount of liquid funds available to Privi Speciality. |
Is Privi Speciality A Good Buy For Long Term?
Privi Speciality, with a market cap of ₹4,316.23 Crore, has exhibited stable growth with a consistent revenue generation of ₹1,752.23 Crore and a net income of ₹94.9 Crore. Despite a debt of ₹1,008.18 Crore, it maintains a healthy cash balance of ₹68.34 Crore. While past returns show volatility, its long-term performance has been strong with significant growth in the past 3, 5, and 10 years. Considering these factors, Privi Speciality can be considered a good buy for long-term investment with potential for steady returns and capital appreciation. However, investors should monitor its debt situation and overall market conditions before making any investment decisions.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
